{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Phoenix",
      "state": "AZ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "92898",
      "recalling_firm": "Central Admixture Pharmacy Services, Inc.",
      "address_1": "2200 S 43rd Ave",
      "address_2": "N/A",
      "postal_code": "85043-3909",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-1138-2023",
      "product_description": "dilTIAZem 125mg/125mL (1 mg/mL), added to dextrose 5%,  IV Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6054-1",
      "product_quantity": "703 bags.",
      "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles",
      "recall_initiation_date": "20230817",
      "center_classification_date": "20230828",
      "termination_date": "20250327",
      "report_date": "20230906",
      "code_info": "Lot# 36-260048, Exp 9/13/2023; 36-262174, Exp 9/15/2023; 36-262523, Exp 9/19/2023.                  ;"
    }
  ]
}